About other CHILDREN'S SPECIFIC growth-related CONDITIONS

Growth hormone (GH) plays a key role in the body’s growth and other processes. For children who are not growing and have Noonan Syndrome (NS), who are short (in stature) born small (Small for Gestational Age-SGA) and no catch-up growth by 2 years, and with Idiopathic Short Stature (ISS), a once-weekly GH injection could be an effective treatment option. 

Actor portrayal

Click the arrow on any tab to learn more about a specific growth-related condition.

Understanding Idiopathic Short Stature (ISS)

What is Idiopathic Short Stature?

In medicine, the word “idiopathic” describes any health condition where the cause is unknown. Children with ISS are shorter than other children of the same age, sex, and population group, but doctors can’t identify a specific cause.

asdf

What are the signs of ISS?

Short stature is often the only feature of ISS. Otherwise, children with ISS have typical birth weights, body proportions, and growth hormone levels.

How is ISS diagnosed?

An ISS diagnosis comes after other causes of short stature are ruled out. These causes could include growth hormone deficiency or genetic disorders. To research possible causes, your child’s doctor may take physical measurements and order lab tests.

Your child may also be referred to a specialist called a pediatric endocrinologist. The specialist may order a stimulation or “stim” test, which measures the level of growth hormone in your child’s body.

If none of the tests point to a specific cause, your child may be diagnosed with ISS.

What’s the stim test?

A stim test measures the body’s ability to release the appropriate amount of growth hormone. The test involves artificially stimulating your child’s pituitary gland. Then, your child has a series of blood tests to see how much growth hormone their pituitary gland produces over a period of time.

After the diagnosis

Children diagnosed with ISS may be prescribed growth hormone treatment. This involves taking regular doses of growth hormone to stimulate growth. Your child may have regular follow-up visits to monitor their growth and make sure that treatment is working well.

Understanding Small for Gestational Age (SGA)

What does “small for gestational age” mean?

“Small for gestational age” means a newborn is much smaller than expected. Specifically, babies born with a birth weight and/or length that are approximately below the 3rd percentile may be considered SGA.

“Gestational age” is the age at the current time point in pregnancy or time of birth, based on the point of conception. It includes the time that babies spend growing in the womb. Most babies are born between 37 and 41 weeks of gestation. A gestational age assessment compares a newborn’s weight and/or length against the average weight and length for other babies of the same gestational age. 

Why are some children born SGA?

There isn’t always a clear reason behind SGA. Some factors that may be associated with SGA include genetic defects or problems with the placenta. It can also be caused by issues with the mother’s health, such as malnutrition, chronic high blood pressure, or chronic infections.

Do babies born SGA “catch up”?

Most babies born small for gestational age will reach their expected height and size by the time they turn 2. Catch-up for babies who are born prematurely may take longer.

If catch-up growth isn’t seen by the age of 2 or 3, your child’s doctor may refer them to a pediatric endocrinologist.

How is SGA diagnosed?

SGA is defined by a child’s size, so doctors may take several measurements of the child’s body and map the results on a growth chart.

Doctors may also perform multiple tests to determine what is causing or contributing to the short stature of a child born SGA. These may include tests to see if a child has growth hormone deficiency or problems with their thyroid (a gland in the neck that produces hormones). Doctors may also do blood tests to look for celiac disease, kidney problems, and other conditions unrelated to hormones.

The results of these tests may help doctors determine what kind of treatment the child needs.

After the diagnosis

Children diagnosed as SGA may be prescribed growth hormone therapy. This involves taking regular doses of growth hormone to stimulate growth. Your child may have regular follow-up visits to monitor their growth and make sure that treatment is working well.

Understanding Noonan Syndrome (NS)

What is Noonan Syndrome (NS)?

Noonan Syndrome is a rare genetic disorder that can affect both boys and girls. About 1 in 1,000 to 2,500 infants are born with NS. 

NS can have a variety of effects on a child’s health and development, including short stature, heart defects present at birth, and certain distinctive facial features.

What causes NS?

NS is caused by a genetic mutation or abnormality. A number of genes are associated with NS, but about half of all cases are caused by a mutation on a gene found on chromosome 12.


If a parent has NS, there is a 50% chance that they will pass the genetic mutation onto their child.

What are the physical features of NS?

Certain features are common among children with NS. Some children may have many of these features, while others have just a few.

Short stature

  • Many children with Noonan Syndrome may have short stature
  • They may have typical weight and length at birth but fall behind during childhood 

Facial features

  • Wide-set eyes
  • Down-slanting eyes
  • Drooping eyelids
  • Arched eyebrows
  • Low-set ears with forward-facing lobes

Other characteristics

  • Webbed neck
  • Chest and skeletal abnormalities
  • A low hairline at the back of the neck
  • Undescended testicles in boys at birth
  • Pale blue or blue-green eyes
  • Heart defects
  • Feeding difficulties in infancy
  • Unusual bleeding or bruising
  • Puffy hands and feet (lymphedema)

How is NS diagnosed?

A doctor or specialist may suspect NS based on your child’s physical features. From there, they may recommend genetic testing. This confirms the diagnosis by revealing any genetic mutations your child may have.

After the diagnosis

Children diagnosed with NS may be prescribed growth hormone therapy. This involves taking regular doses of growth hormone to stimulate growth. Your child may have regular follow-up visits to monitor their growth and make sure that treatment is working well.

Ready? Set? Grow!

Hear from GH families

Kids and parents are speaking out about why they made treatment changes—and why it matters.

Find out more

Get insurance support and find savings

Find out about support programs as you start your GH journey by contacting Novocare® directly at 1-888-668-6444 or clicking below.

Get started
Show more Show less

Important Safety Information

Do not use Sogroya® if:

  • you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing problems
  • you have cancer or other tumors
  • you are allergic to somapacitan-beco or any of the ingredients in Sogroya®
  • your healthcare provider tells you that you have certain types of eye problems caused by diabetes
  • you are a child with closed bone growth plates
  • you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stopping breathing during sleep)

Before taking Sogroya®, tell your healthcare provider about all of your medical conditions, including if you:

  • have had heart or stomach surgery, trauma, or serious breathing problems
  • have had cancer or any tumor
  • have diabetes
  • have adrenal gland problems
  • are taking replacement therapy with glucocorticoids
  • have thyroid gland problems
  • have liver problems
  • are a child with a history of worsening of curvature of the spine (scoliosis)
  • are pregnant or plan to become pregnant. It is not known if Sogroya® will harm your unborn baby. Talk to your healthcare provider if you are pregnant or plan to become pregnant
  • are breastfeeding or plan to breastfeed. It is not known if Sogroya® passes into your breast milk. You and your healthcare provider should decide if you will take Sogroya® while you breastfeed

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Sogroya® may affect the way some medicines work, and some medicines may affect how Sogroya® works.

How should I use Sogroya®?

  • Use Sogroya® exactly as your healthcare provider tells you to
  • Use Sogroya® 1 time each week
  • If you miss a dose of Sogroya®, the missed dose can be taken within 3 days (72 hours) after the scheduled dosing day. One-time weekly dosing for the next dose can be started again on the regularly scheduled dosing day
  • If more than 3 days (72 hours) have passed, skip the missed dose, and take your next dose on the regularly scheduled dosing day
  • Sogroya® pens are for use by 1 person only
  • Do not share your Sogroya® pens and needles with another person, even if the needle has been changed. You may give another person an infection or get an infection from them

What are the possible side effects of Sogroya®?

Sogroya® may cause serious side effects, including:

  • high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma, or serious breathing problems
  • increased risk of growth of cancer or a tumor that is already present and increased risk of the return of cancer or a tumor in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. Your or your child’s healthcare provider will need to monitor you or your child for a return of cancer or a tumor. Contact the healthcare provider if you or your child start to have sudden changes in behavior, headaches, vision problems, or changes in moles, birthmarks, or the color of your or your child’s skin
  • new or worsening high blood sugar (hyperglycemia) or diabetes. You or your child’s blood sugar may need to be monitored during treatment with Sogroya®
  • increase in pressure in the skull (intracranial hypertension). If you or your child have headaches, eye problems, nausea or vomiting, contact the healthcare provider
  • serious allergic reactions. Get medical help right away if you or your child have the following symptoms: swelling of your face, lips, mouth, or tongue, trouble breathing, wheezing, severe itching, skin rashes, redness, or swelling, dizziness or fainting, fast heartbeat or pounding in your chest, sweating
  • your or your child’s body holding too much fluid (fluid retention) such as swelling in the hands and feet, pain in your or your child’s joints or muscles or nerve problems that cause pain, burning or tingling in the hands, arms, legs, and feet. Tell your or your child’s healthcare provider if you or your child have any of these signs or symptoms of fluid retention
  • decrease in a hormone called cortisol. The healthcare provider will do blood tests to check your or your child’s cortisol levels. Tell your or your child’s healthcare provider if you or your child have darkening of the skin, severe fatigue, dizziness, weakness, or weight loss
  • decrease in thyroid hormone levels. Decreased thyroid hormone levels may affect how well Sogroya® works. The healthcare provider will do blood tests to check you or your child’s thyroid hormone levels
  • severe and constant abdominal pain. This could be a sign of pancreatitis. Tell your or your child’s healthcare provider if you or your child has any new abdominal pain
  • loss of fat and tissue weakness in the area of skin you or your child inject. Talk to your or your child’s healthcare provider about rotating the areas where you or your child inject Sogroya®
  • worsening of curvature of the spine in children (scoliosis)
  • hip and knee pain or a limp in children (slipped capital femoral epiphysis). This may lead to a serious condition where bone tissue dies due to lack of blood supply (osteonecrosis). Get medical help right away if your child develops a limp or has hip or knee pain
  • high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems, including sleep apnea
  • increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood. You or your child’s healthcare provider will do blood tests to check this

The most common side effects of Sogroya® in children include: cough, common cold, diarrhea, ear infection, headache, fever, pain in extremity, reaction to injection, respiratory tract infection, and vomiting 

The most common side effects of Sogroya® in adults include: back pain, joint pain, indigestion, sleep problems, dizziness, swelling of the tonsils (tonsillitis), swelling in the feet and hands (peripheral edema), vomiting, low cortisol levels (adrenal insufficiency), high blood pressure, increase in the level of an enzyme in your blood called creatine phosphokinase, weight gain, and low red blood cells (anemia)

Please click here for Sogroya® Prescribing Information.

Sogroya® is a prescription medication. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

What is Sogroya®?

  • Sogroya® (somapacitan-beco) injection 5 mg, 10 mg or 15 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the body. Sogroya® is given by injection under the skin (subcutaneous).
  • Sogroya® is used to treat children 2.5 years of age and older who:
    • are not growing because of low or no growth hormone
    • are short (in stature) and were born small (Small for Gestational Age-SGA) and have not caught up in growth by age 2 years
    • are not growing and have Noonan Syndrome (NS)
    • have Idiopathic Short Stature (ISS)
  • Sogroya® is used to treat adults who do not make enough growth hormone

What is Sogroya®?

  • Sogroya® (somapacitan-beco) injection 5 mg, 10 mg or 15 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the body. Sogroya® is given by injection under the skin (subcutaneous).
  • Sogroya® is used to treat children 2.5 years of age and older who:
    • are not growing because of low or no growth hormone
    • are short (in stature) and were born small (Small for Gestational Age-SGA) and have not caught up in growth by age 2 years
    • are not growing and have Noonan Syndrome (NS)
    • have Idiopathic Short Stature (ISS)
  • Sogroya® is used to treat adults who do not make enough growth hormone

Show more Show less
Show more Show less

What is Sogroya®?

  • Sogroya® (somapacitan-beco) injection 5 mg, 10 mg or 15 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the body. Sogroya® is given by injection under the skin (subcutaneous).
  • Sogroya® is used to treat children 2.5 years of age and older who:
    • are not growing because of low or no growth hormone
    • are short (in stature) and were born small (Small for Gestational Age-SGA) and have not caught up in growth by age 2 years
    • are not growing and have Noonan Syndrome (NS)
    • have Idiopathic Short Stature (ISS)
  • Sogroya® is used to treat adults who do not make enough growth hormone

What is Sogroya®?

  • Sogroya® (somapacitan-beco) injection 5 mg, 10 mg or 15 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the body. Sogroya® is given by injection under the skin (subcutaneous).
  • Sogroya® is used to treat children 2.5 years of age and older who:
    • are not growing because of low or no growth hormone
    • are short (in stature) and were born small (Small for Gestational Age-SGA) and have not caught up in growth by age 2 years
    • are not growing and have Noonan Syndrome (NS)
    • have Idiopathic Short Stature (ISS)
  • Sogroya® is used to treat adults who do not make enough growth hormone

Important Safety Information

Do not use Sogroya® if:

  • you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing problems
  • you have cancer or other tumors
  • you are allergic to somapacitan-beco or any of the ingredients in Sogroya®
  • your healthcare provider tells you that you have certain types of eye problems caused by diabetes
  • you are a child with closed bone growth plates
  • you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stopping breathing during sleep)

Important Safety Information

Do not use Sogroya® if:

  • you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing problems
  • you have cancer or other tumors
  • you are allergic to somapacitan-beco or any of the ingredients in Sogroya®
  • your healthcare provider tells you that you have certain types of eye problems caused by diabetes
  • you are a child with closed bone growth plates
  • you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stopping breathing during sleep)

Before taking Sogroya®, tell your healthcare provider about all of your medical conditions, including if you:

  • have had heart or stomach surgery, trauma, or serious breathing problems
  • have had cancer or any tumor
  • have diabetes
  • have adrenal gland problems
  • are taking replacement therapy with glucocorticoids
  • have thyroid gland problems
  • have liver problems
  • are a child with a history of worsening of curvature of the spine (scoliosis)
  • are pregnant or plan to become pregnant. It is not known if Sogroya® will harm your unborn baby. Talk to your healthcare provider if you are pregnant or plan to become pregnant
  • are breastfeeding or plan to breastfeed. It is not known if Sogroya® passes into your breast milk. You and your healthcare provider should decide if you will take Sogroya® while you breastfeed

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Sogroya® may affect the way some medicines work, and some medicines may affect how Sogroya® works.

How should I use Sogroya®?

  • Use Sogroya® exactly as your healthcare provider tells you to
  • Use Sogroya® 1 time each week
  • If you miss a dose of Sogroya®, the missed dose can be taken within 3 days (72 hours) after the scheduled dosing day. One-time weekly dosing for the next dose can be started again on the regularly scheduled dosing day
  • If more than 3 days (72 hours) have passed, skip the missed dose, and take your next dose on the regularly scheduled dosing day
  • Sogroya® pens are for use by 1 person only
  • Do not share your Sogroya® pens and needles with another person, even if the needle has been changed. You may give another person an infection or get an infection from them

What are the possible side effects of Sogroya®?

Sogroya® may cause serious side effects, including:

  • high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma, or serious breathing problems
  • increased risk of growth of cancer or a tumor that is already present and increased risk of the return of cancer or a tumor in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. Your or your child’s healthcare provider will need to monitor you or your child for a return of cancer or a tumor. Contact the healthcare provider if you or your child start to have sudden changes in behavior, headaches, vision problems, or changes in moles, birthmarks, or the color of your or your child’s skin
  • new or worsening high blood sugar (hyperglycemia) or diabetes. You or your child’s blood sugar may need to be monitored during treatment with Sogroya®
  • increase in pressure in the skull (intracranial hypertension). If you or your child have headaches, eye problems, nausea or vomiting, contact the healthcare provider
  • serious allergic reactions. Get medical help right away if you or your child have the following symptoms: swelling of your face, lips, mouth, or tongue, trouble breathing, wheezing, severe itching, skin rashes, redness, or swelling, dizziness or fainting, fast heartbeat or pounding in your chest, sweating
  • your or your child’s body holding too much fluid (fluid retention) such as swelling in the hands and feet, pain in your or your child’s joints or muscles or nerve problems that cause pain, burning or tingling in the hands, arms, legs, and feet. Tell your or your child’s healthcare provider if you or your child have any of these signs or symptoms of fluid retention
  • decrease in a hormone called cortisol. The healthcare provider will do blood tests to check your or your child’s cortisol levels. Tell your or your child’s healthcare provider if you or your child have darkening of the skin, severe fatigue, dizziness, weakness, or weight loss
  • decrease in thyroid hormone levels. Decreased thyroid hormone levels may affect how well Sogroya® works. The healthcare provider will do blood tests to check you or your child’s thyroid hormone levels
  • severe and constant abdominal pain. This could be a sign of pancreatitis. Tell your or your child’s healthcare provider if you or your child has any new abdominal pain
  • loss of fat and tissue weakness in the area of skin you or your child inject. Talk to your or your child’s healthcare provider about rotating the areas where you or your child inject Sogroya®
  • worsening of curvature of the spine in children (scoliosis)
  • hip and knee pain or a limp in children (slipped capital femoral epiphysis). This may lead to a serious condition where bone tissue dies due to lack of blood supply (osteonecrosis). Get medical help right away if your child develops a limp or has hip or knee pain
  • high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems, including sleep apnea
  • increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood. You or your child’s healthcare provider will do blood tests to check this

The most common side effects of Sogroya® in children include: cough, common cold, diarrhea, ear infection, headache, fever, pain in extremity, reaction to injection, respiratory tract infection, and vomiting 

The most common side effects of Sogroya® in adults include: back pain, joint pain, indigestion, sleep problems, dizziness, swelling of the tonsils (tonsillitis), swelling in the feet and hands (peripheral edema), vomiting, low cortisol levels (adrenal insufficiency), high blood pressure, increase in the level of an enzyme in your blood called creatine phosphokinase, weight gain, and low red blood cells (anemia)

Please click here for Sogroya® Prescribing Information.

Sogroya® is a prescription medication. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Important Safety Information

Do not use Sogroya® if:

  • you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing problems
  • you have cancer or other tumors
  • you are allergic to somapacitan-beco or any of the ingredients in Sogroya®
  • your healthcare provider tells you that you have certain types of eye problems caused by diabetes
  • you are a child with closed bone growth plates
  • you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stopping breathing during sleep)

Before taking Sogroya®, tell your healthcare provider about all of your medical conditions, including if you:

  • have had heart or stomach surgery, trauma, or serious breathing problems
  • have had cancer or any tumor
  • have diabetes
  • have adrenal gland problems
  • are taking replacement therapy with glucocorticoids
  • have thyroid gland problems
  • have liver problems
  • are a child with a history of worsening of curvature of the spine (scoliosis)
  • are pregnant or plan to become pregnant. It is not known if Sogroya® will harm your unborn baby. Talk to your healthcare provider if you are pregnant or plan to become pregnant
  • are breastfeeding or plan to breastfeed. It is not known if Sogroya® passes into your breast milk. You and your healthcare provider should decide if you will take Sogroya® while you breastfeed

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Sogroya® may affect the way some medicines work, and some medicines may affect how Sogroya® works.

How should I use Sogroya®?

  • Use Sogroya® exactly as your healthcare provider tells you to
  • Use Sogroya® 1 time each week
  • If you miss a dose of Sogroya®, the missed dose can be taken within 3 days (72 hours) after the scheduled dosing day. One-time weekly dosing for the next dose can be started again on the regularly scheduled dosing day
  • If more than 3 days (72 hours) have passed, skip the missed dose, and take your next dose on the regularly scheduled dosing day
  • Sogroya® pens are for use by 1 person only
  • Do not share your Sogroya® pens and needles with another person, even if the needle has been changed. You may give another person an infection or get an infection from them

What are the possible side effects of Sogroya®?

Sogroya® may cause serious side effects, including:

  • high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma, or serious breathing problems
  • increased risk of growth of cancer or a tumor that is already present and increased risk of the return of cancer or a tumor in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. Your or your child’s healthcare provider will need to monitor you or your child for a return of cancer or a tumor. Contact the healthcare provider if you or your child start to have sudden changes in behavior, headaches, vision problems, or changes in moles, birthmarks, or the color of your or your child’s skin
  • new or worsening high blood sugar (hyperglycemia) or diabetes. You or your child’s blood sugar may need to be monitored during treatment with Sogroya®
  • increase in pressure in the skull (intracranial hypertension). If you or your child have headaches, eye problems, nausea or vomiting, contact the healthcare provider
  • serious allergic reactions. Get medical help right away if you or your child have the following symptoms: swelling of your face, lips, mouth, or tongue, trouble breathing, wheezing, severe itching, skin rashes, redness, or swelling, dizziness or fainting, fast heartbeat or pounding in your chest, sweating
  • your or your child’s body holding too much fluid (fluid retention) such as swelling in the hands and feet, pain in your or your child’s joints or muscles or nerve problems that cause pain, burning or tingling in the hands, arms, legs, and feet. Tell your or your child’s healthcare provider if you or your child have any of these signs or symptoms of fluid retention
  • decrease in a hormone called cortisol. The healthcare provider will do blood tests to check your or your child’s cortisol levels. Tell your or your child’s healthcare provider if you or your child have darkening of the skin, severe fatigue, dizziness, weakness, or weight loss
  • decrease in thyroid hormone levels. Decreased thyroid hormone levels may affect how well Sogroya® works. The healthcare provider will do blood tests to check you or your child’s thyroid hormone levels
  • severe and constant abdominal pain. This could be a sign of pancreatitis. Tell your or your child’s healthcare provider if you or your child has any new abdominal pain
  • loss of fat and tissue weakness in the area of skin you or your child inject. Talk to your or your child’s healthcare provider about rotating the areas where you or your child inject Sogroya®
  • worsening of curvature of the spine in children (scoliosis)
  • hip and knee pain or a limp in children (slipped capital femoral epiphysis). This may lead to a serious condition where bone tissue dies due to lack of blood supply (osteonecrosis). Get medical help right away if your child develops a limp or has hip or knee pain
  • high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems, including sleep apnea
  • increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood. You or your child’s healthcare provider will do blood tests to check this

The most common side effects of Sogroya® in children include: cough, common cold, diarrhea, ear infection, headache, fever, pain in extremity, reaction to injection, respiratory tract infection, and vomiting 

The most common side effects of Sogroya® in adults include: back pain, joint pain, indigestion, sleep problems, dizziness, swelling of the tonsils (tonsillitis), swelling in the feet and hands (peripheral edema), vomiting, low cortisol levels (adrenal insufficiency), high blood pressure, increase in the level of an enzyme in your blood called creatine phosphokinase, weight gain, and low red blood cells (anemia)

Please click here for Sogroya® Prescribing Information.

Sogroya® is a prescription medication. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

What is Sogroya®?

  • Sogroya® (somapacitan-beco) injection 5 mg, 10 mg or 15 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the body. Sogroya® is given by injection under the skin (subcutaneous).
  • Sogroya® is used to treat children 2.5 years of age and older who:
    • are not growing because of low or no growth hormone
    • are short (in stature) and were born small (Small for Gestational Age-SGA) and have not caught up in growth by age 2 years
    • are not growing and have Noonan Syndrome (NS)
    • have Idiopathic Short Stature (ISS)
  • Sogroya® is used to treat adults who do not make enough growth hormone

What is Sogroya®?

  • Sogroya® (somapacitan-beco) injection 5 mg, 10 mg or 15 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the body. Sogroya® is given by injection under the skin (subcutaneous).
  • Sogroya® is used to treat children 2.5 years of age and older who:
    • are not growing because of low or no growth hormone
    • are short (in stature) and were born small (Small for Gestational Age-SGA) and have not caught up in growth by age 2 years
    • are not growing and have Noonan Syndrome (NS)
    • have Idiopathic Short Stature (ISS)
  • Sogroya® is used to treat adults who do not make enough growth hormone

You are about to leave Sogroya.com, a Novo Nordisk website

Click “Continue” to leave the site and come back to visit us another time. Click “Return to site” to stay and learn more about Sogroya® (somapacitan-beco) injection.

Continue

You are about to leave Sogroya.com, a Novo Nordisk website

Click “Continue” to leave the site. Novo Nordisk isn’t responsible for the following content. Come back to visit us another time.

Click “Return to site” to stay and learn more about Sogroya® (somapacitan-beco) injection.

Continue